2024
Impact of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Chronic Kidney Disease: A Middle East and Africa Perspective
Elkeraie A, Al-Ghamdi S, Abu-Alfa A, Alotaibi T, AlSaedi A, AlSuwaida A, Arici M, Ecder T, Ghnaimat M, Hafez M, Hassan M, Sqalli T. Impact of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Chronic Kidney Disease: A Middle East and Africa Perspective. International Journal Of Nephrology And Renovascular Disease 2024, 17: 1-16. PMID: 38196830, PMCID: PMC10771977, DOI: 10.2147/ijnrd.s430532.Peer-Reviewed Original ResearchChronic kidney diseaseSodium-glucose cotransporter 2 inhibitorsCotransporter 2 inhibitorsDiabetes mellitusKidney diseaseType 2 diabetes mellitusMajor public health concernAldosterone system inhibitorsBetter clinical outcomesCause of deathPublic health concernNephrology referralCKD managementClinical outcomesSystem inhibitorsCardioprotective propertiesEarly initiationTreatment pathwaysConsensus recommendationsHigh riskPatientsBetter careHealth concernEarly detectionHypertension
2021
May Measurement Month 2019: an analysis of blood pressure screening results from Lebanon
Najem RN, Halawi A, Tanios B, Ambriss R, Bikai RE, Partington G, Beaney T, Poulter NR, Abu Alfa A. May Measurement Month 2019: an analysis of blood pressure screening results from Lebanon. European Heart Journal Supplements 2021, 23: b92-b94. PMID: 34248434, PMCID: PMC8263084, DOI: 10.1093/eurheartj/suab037.Peer-Reviewed Original ResearchBlood pressureAntihypertensive medicationsLebanese populationImportant public health concernPrevalence of hypertensionBlood pressure readingsTreatment of hypertensionSilent killer diseasePublic health concernCross-sectional surveyOne-thirdHypertensive populationHypertension prevalenceDiastolic BPAnnual screeningBetter prognosisLifestyle factorsMean ageHigh prevalenceHypertensionMortality rateKiller diseasePressure readingsRapid interventionHealth concern